Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MÜLLER-HOLZNER, Elisabeth")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 32

  • Page / 2
Export

Selection :

  • and

Human papillomavirus DNA in sera of cervical cancer patients as tumor markerWIDSCHWENDTER, Andreas; BLASSNIG, Anya; WIEDEMAIR, Annemarie et al.Cancer letters. 2003, Vol 202, Num 2, pp 231-239, issn 0304-3835, 9 p.Article

Activated p38-MAPK and Gemcitabine Sensitivity in Recurrent Ovarian CancerKLOTZ, Renate; GUSTAVE ZEIMET, Alain; REIMER, Daniel et al.Anticancer research. 2008, Vol 28, Num 5B, pp 2975-2980, issn 0250-7005, 6 p.Article

Infiltrating CD11b+CD11c+ cells have the potential to mediate inducible nitric oxide synthase-dependent cell death in mammary carcinomas of HER-2/neu transgenic micePARAJULI, Nirmala; MÜLLER-HOLZNER, Elisabeth; BÖCK, Günther et al.International journal of cancer (Print). 2010, Vol 126, Num 4, pp 896-908, issn 0020-7136, 13 p.Article

Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patientsGÖBEL, Georg; AUER, Doris; GAUGG, Inge et al.Breast cancer research and treatment. 2011, Vol 130, Num 1, pp 109-117, issn 0167-6806, 9 p.Article

Analysis of methylated genes in peritoneal fluids of ovarian cancer patients: A new prognostic toolMÜLLER, Hannes M; MILLINGER, Simone; FIEGL, Heidi et al.Clinical chemistry (Baltimore, Md.). 2004, Vol 50, Num 11, pp 2171-2173, issn 0009-9147, 3 p.Article

Clinical relevance of E2F family members in ovarian cancer : An evaluation in a training set of 77 patientsREIMER, Daniel; SADR, Susann; WIEDEMAIR, Annemarie et al.Clinical cancer research. 2007, Vol 13, Num 1, pp 144-151, issn 1078-0432, 8 p.Article

Breast cancer DNA methylation profiles in cancer cells and tumor stroma : Association with HER-2/neu status in primary breast cancerFIEGL, Heidi; MILLINGER, Simone; GOEBEL, Georg et al.Cancer research (Baltimore). 2006, Vol 66, Num 1, pp 29-33, issn 0008-5472, 5 p.Article

DNA methylation in serum and tumors of cervical cancer patientsWIDSCHWENDTER, Andreas; MÜLLER, Hannes M; FIEGL, Heidi et al.Clinical cancer research. 2004, Vol 10, Num 2, pp 565-571, issn 1078-0432, 7 p.Article

Interferon-γ expression is an independent prognostic factor in ovarian cancerMARTH, Christian; FIEGL, Heidi; ZEIMET, Alain G et al.American journal of obstetrics and gynecology. 2004, Vol 191, Num 5, pp 1598-1605, issn 0002-9378, 8 p.Article

Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratoriesREGITNIG, Peter; REINER, Angelika; DINGES, Hans-Peter et al.Virchows Archiv. 2002, Vol 441, Num 4, pp 328-334, issn 0945-6317, 7 p.Article

Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancerAUER, Doris; REIMER, Daniel; PORTO, Verena et al.Breast cancer research and treatment. 2009, Vol 116, Num 1, pp 103-111, issn 0167-6806, 9 p.Article

Analysis of aberrant DNA methylation and Human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursorsWIDSCHWENDTER, Andreas; GATTRINGER, Conny; GOEBEL, Georg et al.Clinical cancer research. 2004, Vol 10, Num 10, pp 3396-3400, issn 1078-0432, 5 p.Article

hCDC4 gene mutations in endometrial cancerSPRUCK, Charles H; STROHMAIER, Heimo; SANGFELT, Olle et al.Cancer research (Baltimore). 2002, Vol 62, Num 16, pp 4535-4539, issn 0008-5472Article

L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter EvaluationZEIMET, Alain G; REIMER, Daniel; JAHN, Stephan et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 15, pp 1142-1150, issn 0027-8874, 9 p.Article

Clinical Relevance of TAp73 and ΔNp73 Protein Expression in Ovarian Cancer: A Series of 83 Cases and Review of the LiteratureHOFSTETTER, Gerda; BERGER, Astrid; CONCIN, Nicole et al.International journal of gynecological pathology. 2011, Vol 30, Num 6, pp 527-531, issn 0277-1691, 5 p.Article

Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancerZEIMET, Alain G; REIMER, Daniel; WOLF, Dominik et al.International journal of cancer (Print). 2009, Vol 124, Num 10, pp 2353-2360, issn 0020-7136, 8 p.Article

Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7HÖPFL, Reinhard; HEIM, Kurt; PFISTER, Herbert et al.Lancet (British edition). 2000, Vol 356, Num 9246, pp 1985-1986, issn 0140-6736Article

Detection of Human Papillomavirus Type 18 E7 Oncoprotein in Cervical Smears: a Feasibility StudyEHEHALT, Daniela; LENER, Barbara; HÖFLER, Daniela et al.Journal of clinical microbiology (Print). 2012, Vol 50, Num 2, pp 246-257, issn 0095-1137, 12 p.Article

E2F3a Is Critically Involved in Epidermal Growth Factor Receptor-Directed Proliferation in Ovarian CancerREIMER, Daniel; HUBALEK, Michael; ALTEVOGT, Peter et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 11, pp 4613-4623, issn 0008-5472, 11 p.Article

The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast CancerFILIPITS, Martin; NIELSEN, Torsten O; MÜLLER-HOLZNER, Elisabeth et al.Clinical cancer research (Print). 2014, Vol 20, Num 5, pp 1298-1305, issn 1078-0432, 8 p.Article

Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusionsSALANI, Ritu; DAVIDSON, Ben; LIN, Bai-Ling et al.Clinical cancer research. 2007, Vol 13, Num 19, pp 5805-5809, issn 1078-0432, 5 p.Article

Expression of the high-risk human papillomavirus type 18 and 45 E7 oncoproteins in cervical carcinoma biopsiesFIEDLER, Marc; RESSLER, Sigrun; DÜRST, Matthias et al.Journal of general virology. 2005, Vol 86, pp 3235-3241, issn 0022-1317, 7 p., 12Article

CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patientsWIDSCHWENDTER, Andreas; IVARSSON, Lennart; BLASSNIG, Anya et al.International journal of cancer. 2004, Vol 109, Num 2, pp 163-166, issn 0020-7136, 4 p.Article

MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancerHOFSTETTER, Gerda; BERGER, Astrid; ULMER, Hanno et al.Oncology reports. 2012, Vol 27, Num 3, pp 673-677, issn 1021-335X, 5 p.Article

Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumorsBERGER, Regina; FIEGL, Heidi; MÜLLER-HOLZNER, Elisabeth et al.Cancer science. 2010, Vol 101, Num 4, pp 1059-1066, issn 1347-9032, 8 p.Article

  • Page / 2